The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 2.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (32 analysts) rates it buy, with a mean price target of $330. Insiders have been net sellers over the past quarter.
McDonald's
MCD · a US exchange · USD · Market cap $198.6B · 150,000 employees
McDonald's Corporation owns, operates, and franchises restaurants under the McDonald's brand in the United States and internationally.
FAIL · Does not pass the screenPrice as of 17 Nov 2026Daily close, not a live quote
Screened 2026-11-17 · the tape above runs as of 07:15 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price275.82 USD at the 17 Nov 2026 close
- Our value readOvervalued vs our fair value, as of 17 Nov 2026
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans heavily to calls (put/call 0.35)
- Last reviewed17 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $207.00 to $280.44, base estimate $243.86 (screen dated 2026-11-17).
- Trend Markup
- Insiders insiders sold, $207,930, latest filing 2026-11-13
- Positioning political selling, disclosed 2026-10-27
- Options put/call open interest 0.35, read 2026-11-13
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
McDonald's holds its Markup at $275.82. Consolidating, no directional conviction, held for 2 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 2 days |
| Price at the screen | $275.82 |
| Valuation | 22.27 trailing · 20.58 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.43 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 92.10% | Below 33% | Interest-bearing debt is 92.1% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 4.74% | Below 33% | Cash held in interest-bearing accounts and securities is 4.7% of assets, under the one-third limit. | Pass |
| Receivables | 5.44% | Below 49% | Money owed to the company is 5.4% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.31% | Below 5% | Only 0.3% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
McDonald's's business is in a permissible area, but its interest-bearing debt is about 92% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-17. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when MCD's ethical verdict changes
Today MCD does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 17 Nov 2026: it trades above our $243.86 fair value estimate, 1.10% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-17 screen. The gold marker is the market price at the same screen. The price runs 13.1% above the base estimate.
Third-party analyst targets: 29 covering, consensus Buy. The average target sits +9% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $243.86, with a range of $207.00 to $280.44, dated to the 2026-11-17 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it gives us pause
At 20.6x forward earnings, the price already runs ahead of the business. It trades 13% above our $243.86 fair value, so you would be buying at a premium, not a discount.
| Forward P/E | 20.6xexpensive even after accounting for its growth |
| Trailing P/E | 22.3xa premium valuation |
| EPS, trailing | 12.64 |
| EPS, forward | 13.67 |
| Revenue growth | +1.1%slow but positive growth |
| Profit margin | 32.4%highly profitable on every dollar of sales |
| FCF yield | 2.85% |
| Dividend yield | 2.64% |
| Current ratio | 1.23adequate liquidity, worth monitoring |
| Beta | 0.43barely tracks the market's swings |
| Short interest, float | 0.02% |
| 52-week range | 229.20 - 341.75 |
| Market cap | $198.6B |
| Employees | 150,000 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeMCD trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (32 analysts) rates it buy, with a mean price target of $330. Insiders have been net sellers over the past quarter.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (32 analysts) rates it buy, with a mean price target of $330. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (32 analysts) rates it buy, with a mean price target of $330. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (32 analysts) rates it buy, with a mean price target of $330. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (32 analysts) rates it buy, with a mean price target of $330. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (32 analysts) rates it buy, with a mean price target of $330. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (32 analysts) rates it buy, with a mean price target of $330. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (32 analysts) rates it buy, with a mean price target of $330. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (32 analysts) rates it buy, with a mean price target of $330. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- McDonald's 'Home Alone Meal' offers holiday socks, menu items Yahoo Finance · 13h ago
- Here’s Why This Strategy Exited McDonald’s Corporation (MCD) in Q3 Yahoo Finance · 16h ago
- Has McDonald's Stock Become A Different Bet? Yahoo Finance · 17h ago
- Starbucks' AI-Powered Drive-Thru: Can Technology Improve Efficiency? Yahoo Finance · 18h ago
- What Is The True Hidden Price Of Starbucks Stock? Yahoo Finance · 20h ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-13 | Banner Jonathan | EVP - Chief Impact Officer | S - Sale | 750 | $207,930 |
| 2026-05-26 | Erlinger Joseph M. | S - Sale | Sale | 7,734 | · |
| 2026-04-23 | Erlinger Joseph M. | S - Sale | Sale | 8,067 | · |
| 2026-04-10 | Erlinger Joseph M. | S - Sale+OE | Sale | 8,400 | · |
| 2026-03-23 | Erlinger Joseph M. | S - Sale | Sale | 8,400 | · |
| 2026-03-18 | Baroni Dario | S - Sale | Sale | 1,063 | · |
| 2026-03-10 | Erlinger Joseph M. | S - Sale+OE | Sale | 8,733 | · |
| 2026-02-23 | Erlinger Joseph M. | S - Sale | Sale | 8,733 | · |
| 2026-02-23 | Banner Jonathan | EVP - Chief Impact Officer | Sale | 2,291 | · |
| 2026-02-12 | Kempczinski Christopher J | COB, CEO | Sale | 66,288 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-10-27 | Pete Sessions | Republican | sell | 1K–15K |
| 2026-10-27 | Pete Sessions | Republican | sell | 1K–15K |
| 2026-10-27 | Pete Sessions | Republican | sell | 1K–15K |
| 2026-10-13 | Ro Khanna | Democrat | sell | 15K–50K |
| 2026-10-07 | Ro Khanna | Democrat | buy | 15K–50K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $272.75 | +3.9% | $1.86 | $1,046 | +4.6% |
| 2 months | $303.62 | -6.6% | $1.86 | $940 | -6.0% |
| 3 months | $321.73 | -11.9% | $1.86 | $887 | -11.3% |
| 6 months | $305.91 | -7.3% | $3.72 | $939 | -6.1% |
| 1 year | $293.31 | -3.4% | $7.35 | $992 | -0.8% |
| 2 years | $242.11 | +17.1% | $14.33 | $1,230 | +23.0% |
| 3 years | $267.22 | +6.1% | $20.86 | $1,139 | +13.9% |
| 5 years | $211.22 | +34.2% | $32.23 | $1,495 | +49.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever MCD does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.